Home » Topics » BioWorld Science, Dermatologic

BioWorld Science, Dermatologic
RSS

BARDA awards contract to Stratatech for StrataGraft skin substitute

Oct. 7, 2015

FDA accepts Sandoz BLA for biosimilar etanercept

Oct. 5, 2015

Allergan adds to esthetics assets with Kythera acquisition

Oct. 5, 2015

Novan Therapeutics reports IIb trial data for SB-204 for in acne vulgaris

Oct. 1, 2015

GlaxoSmithKline's Zagallo receives approval in Japan

Sep. 29, 2015

Xenon initiates phase I trial of XEN-801 for acne

Sep. 29, 2015

RepliCel starts phase I trial of autologous fibroblast therapy RCS-01

Sep. 16, 2015

XenoPort reports phase II study data for XP-23829

Sep. 16, 2015

Trevi Therapeutics reports data from phase II/III trial in uremic pruritus

Sep. 15, 2015

FDA approves Humira for moderate to severe hidradenitis suppurativa

Sep. 14, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 13, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...